Recombinant Human Antibody (2558) scFv Fragment is specific to HIV-1 gp160. The neutralizing antibody may define conserved epitopes in the diverse virus envelopes. This will be useful information for designing vaccine immunogen inducing cross-neutralizing Abs.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
CAT | Product Name | Application | Type |
---|---|---|---|
PFBL-382 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone VRC08); Fab Fragment | Neut, FuncS | Human Fab |
MRO-3818CQ-F(E) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone 135/9 (87-135/9)); Fab Fragment | Neut | Mouse Fab |
MRO-3819CQ-F(E) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone 13H8); Fab Fragment | Neut, ELISA | Mouse Fab |
MRO-3820CQ-F(E) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone 14D9); Fab Fragment | ELISA, WB | Mouse Fab |
MRO-3821CQ-F(E) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone 1575); Fab Fragment | ELISA | Mouse Fab |
CAT | Product Name | Application | Type |
---|---|---|---|
PABL-554 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone C38-VRC16.01) | FC, Neut | Human IgG |
PABL-555 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone C38-VRC18.02) | FC, Neut | Human IgG |
PABL-556 | Human Anti-HIV-1 gp160 Recombinant Antibody (PABL-556) | Neut | Human IgG |
PABL-557 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone Z258-VRC27.01) | FC, Neut | Human IgG |
PABC-180 | Human Anti-HIV-1 gp160 Recombinant Antibody (clone 2558) | ELISA, Neut | Human IgG |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-075LC | Anti-HIV-1 gp160 Recombinant Antibody (24G3) | WB, ELISA | Human antibody |
MRO-080LC | Anti-HIV-1 gp160 Recombinant Antibody (81C7) | ELISA | Human antibody |
MRO-091LC | Anti-HIV-1 gp160 Recombinant Antibody (MAb CL1) | ELISA | Human antibody |
MRO-100LC | Anti-HIV-1 gp160 Recombinant Antibody (N7019b) | ELISA | Human antibody |
MRO-075LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (24G3) | ELISA | Human antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-086LC | Anti-HIV-1 gp160 Recombinant Antibody (1C1) | ELISA | Mouse antibody |
MRO-087LC | Anti-HIV-1 gp160 Recombinant Antibody (1H9) | ELISA | Mouse antibody |
MRO-089LC | Anti-HIV-1 gp160 Recombinant Antibody (2H8) | ELISA | Mouse antibody |
MRO-086LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (1C1) | ELISA | Mouse antibody |
MRO-087LC-F(E) | Anti-HIV-1 gp160 Recombinant Antibody Fab Fragment (1H9) | ELISA | Mouse antibody |
CAT | Product Name | Application | Type |
---|---|---|---|
MRO-3849CQ-S(P) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone C8); scFv Fragment | ELISA, WB | Mouse scFv |
MRO-3850CQ-S(P) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone CA13 (ARP3119)); scFv Fragment | ELISA | Mouse scFv |
MRO-3851CQ-S(P) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone D19); scFv Fragment | Neut | Mouse scFv |
MRO-3852CQ-S(P) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone D49); scFv Fragment | ELISA, WB | Mouse scFv |
MRO-3853CQ-S(P) | Mouse Anti-HIV-1 gp160 Recombinant Antibody (clone F19.26-4); scFv Fragment | Neut | Mouse scFv |
There are currently no Customer reviews or questions for PSBC-180. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.